MAIDENHEAD, UK, Feb. 26, 2025 — ‘One cupcake won’t kill you’, ‘I’m going to get diabetes just looking at that’, ‘That person doesn’t look like they have diabetes.’ New survey results and a film released today by Abbott highlight how everyday comments like these may affect people living with diabetes.
People living with diabetes face many barriers to receiving care. Survey data reveal that the misconceptions and stereotypes around the condition can weigh heavily on the minds of those living with diabetes, creating one more barrier and potentially preventing them from managing their health.
"How many times have we heard ‘That looks like diabetes on a plate’ when we’re watching a movie, eating at a restaurant or scrolling through social media?" said Dr. Susan Guzman, Behavioral Diabetes Institute co-founder, clinical psychologist, and diabetes specialist. "After more than two decades of research and working with people managing stigma, I can tell you that misconceptions around diabetes take a real toll on people. If we want to help people manage their health, we have to recognise where and how bias around diabetes exists and promote a compassionate and fact-based understanding of diabetes."
Data1 from a survey of more than 2,600 people living with diabetes across eight countries, including the U.K, highlights they may not be getting the care they need due to the shame and stigma around their condition, which can lead to real and often unnoticed health consequences:
Additional biometric testing revealed that nearly 40% of individuals had an elevated physiological response to stigmatising statements, even if they don’t show outward signs or expressions.1
But while words can hurt, they can also help.
Above the Bias
Abbott’s new Above the Bias initiative aims to help others see the world from the perspective of someone living with diabetes. The initiative builds upon efforts by several diabetes organisations, patient advocacy groups, and experts that continue to work to reduce stigma about diabetes3. People can learn more about Above the Bias and watch the film at AboveBias.com.
"From the very early days of Libre, it’s been our job to make living with diabetes easier," said Chris Scoggins, executive vice president of Abbott’s diabetes care business. "But technology alone can’t fix every barrier that people face. We’re committed to doing our part, but we can’t do it alone. We need the ongoing help of others to support people living with diabetes, so they can get the care they need to manage their health."
About FreeStyle Libre:
Abbott continues to pioneer ground-breaking technology to support people living with diabetes. The company revolutionized diabetes care 10 years ago with its world-leading FreeStyle Libre continuous glucose monitoring portfolio, which today is used by about
7 million people in more than 60 countries4. People use Libre to see their glucose numbers in real-time, making it easier to act, such as taking insulin or adjusting food and activity, to make progress on their health goals.
About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
Connect with us at Abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube.
Abbott Media:
Bill Ranatunga, (+44) 7379 07 07 18
References
1 Data on file. Research conducted by Savanta on behalf of Abbott between May and August 2024 was executed in three distinct phases among people with diabetes across Canada, France, Germany, Ireland, Italy, Japan, the UK, and the US.
2 National Diabetes Statistics Report, U.S. Centers for Disease Control and Prevention: National Diabetes Statistics Report | Diabetes | CDC
3 J. Speight, E. Holmes-Truscott, M. Garza et al. Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations. Published January 2024 DOI: https://doi.org/10.1016/S2213-8587(23)00347-9
4 Data on File. Abbott Diabetes Care
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT